Would an IMI work in Japan? EFPIA thinks so
This article was originally published in Scrip
Executive Summary
Speaking as the president of the European pharmaceutical industry federation EFPIA, Christopher Viehbacher is quite clear that change and innovation in all areas, ranging from R&D to regulatory approaches to new drugs themselves, are essential if healthcare systems are to prosper.